Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Mabwell Announces Clinical Trial Progress of 9MW2821 in Triple-Negative Breast Cancer 2024-05-13 22:00
Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Macau 2024-05-08 08:05
YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer 2024-05-08 04:20
FDA Grants Orphan Drug Designation to 9MW2821 2024-05-07 22:00
Palm Oil Giant Musim Mas Pledges Third Tranche of S$5 million In Boost to Local Charities 2024-05-06 09:00
Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry 2024-05-01 17:14
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 2024-04-29 20:00
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 2024-04-29 20:00
INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics 2024-04-29 12:00
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil 2024-04-25 21:41
GSK Advocates Importance of Adult Immunisation amongst Malaysians 2024-04-25 14:53
Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19 2024-04-22 19:52
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards 2024-04-22 09:00
Juniper Biologics Named "Pharmaceutical Company of the Year" at Corporate LiveWire Global Awards 2024-04-22 09:00
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success 2024-04-19 21:00
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization 2024-04-19 13:17
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization 2024-04-19 10:54
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine 2024-04-18 20:00
TaiGen Successfully Completes TG-1000 Phase III Study 2024-04-18 11:03
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA 2024-04-17 14:03
1 2 3 4 5 226